Related Experiment Video
Updated: Apr 15, 2026

Murine Prostate Micro-dissection and Surgical Castration
Published on: May 11, 2016
Implications of ubiquitin ligases in castration-resistant prostate cancer
Jianfei Qi1, Lingling Fan, Arif Hussain
1aDepartment of Biochemistry and Molecular Biology bGreenebaum Cancer Center, University of Maryland School of Medicine cBaltimore VA Medical Center, Baltimore, Maryland, USA.
Purpose Of Review:
Significant advances have been made in the study of ubiquitination-mediated regulation of androgen receptor (AR). This review will highlight the latest developments in the mechanisms by which E3 ubiquitin ligases control AR activity, with implications in castration-resistant prostate cancer (CRPC).
Recent Findings:
Several ubiquitin ligases have been identified to interact with and ubiquitinate AR, and consequently regulate the AR transcriptional programme. Different ubiquitin ligases can use distinct mechanisms to modulate the expression of AR target genes, including local turnover of AR chromatin complex, recruitment of AR coactivators and global AR stability. The expression or activity of ubiquitin ligases can be altered in prostate cancer and thus contribute to the growth of androgen-insensitive prostate cancer cells by modulating the AR transcriptional activity.
Summary:
Understanding the regulation of AR transcriptional activity by ubiquitin ligases will contribute to the elucidation of mechanisms underlying AR reactivation that is believed to drive the development of CRPC. Ubiquitin ligases could potentially serve as promising targets for developing therapeutics in the treatment of advanced prostate cancers.
Insights
E3 ubiquitin ligases regulate androgen receptor (AR) activity, impacting castration-resistant prostate cancer (CRPC). Understanding these mechanisms offers potential therapeutic targets for advanced prostate cancer.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Androgen receptor (AR) plays a critical role in prostate cancer progression.
- Ubiquitination is a key post-translational modification regulating protein function.
- Dysregulation of AR signaling is a hallmark of castration-resistant prostate cancer (CRPC).
Purpose of the Study:
- To review the latest advancements in the ubiquitination-mediated regulation of AR.
- To elucidate the mechanisms by which E3 ubiquitin ligases control AR activity.
- To discuss the implications of these mechanisms in CRPC.
Main Methods:
- Literature review of studies on E3 ubiquitin ligases and AR.
- Analysis of mechanisms regulating AR activity through ubiquitination.
- Examination of the role of E3 ligases in prostate cancer development.
Main Results:
- Multiple E3 ubiquitin ligases interact with and ubiquitinate AR, modulating its transcriptional program.
- Mechanisms include regulating AR chromatin complex turnover, recruiting coactivators, and controlling global AR stability.
- Altered E3 ligase expression or activity in prostate cancer promotes androgen-insensitive cell growth via AR modulation.
Conclusions:
- Understanding E3 ligase regulation of AR is crucial for elucidating AR reactivation in CRPC.
- E3 ubiquitin ligases represent promising therapeutic targets for advanced prostate cancer treatment.
More Related Videos
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Anaphase Promoting Complex
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

